Mkts

ADMA Biologics Inc

NASDAQ: ADMA
$13.68+0.44 (+3.32%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
13.0714.02
52-week range
7.2120.46
Today
Open13.29
Previous close13.68
Volume3.77M
Valuation
Market cap2.94B
P/E ratio17.39×
EPS (TTM)0.71
Income & risk
Dividend / yield—
Beta0.69
Avg volume2.98M
Discussion

ADMA News

Stories mentioning ADMA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue114,493139,163134,224121,984114,802117,549119,839107,191
Cost of Goods Sold33,74350,34858,59854,75753,70554,21660,18049,738
Gross Profit80,75088,81575,62667,22761,09763,33359,65957,453
Operating Expenses
Research & Development2,5971,3771,5281,031826.00391.00412.00560.00
Sales General & Admin26,74223,51121,77622,21424,07923,31718,56016,608
Total Operating Expenses22,47626,06324,61424,42926,21625,01020,02118,252
Operating Income (Loss)58,27462,75251,01242,79834,88138,32339,63839,201
Interest Income487.00376.00400.00608.00598.00666.00449.00
Interest Expense
Other Expense(140.00)(19.00)(21.00)(108.00)(64.00)(86.00)(56.00)(16.00)
Pretax Income57,12761,59447,51540,09733,45034,71336,74935,851
Tax Provision11,79912,21511,0875,8786,546(77,183)840.003,789
Net Income (Loss)45,32849,37936,42834,21926,904111,89635,90932,062
Earnings Per Share (Basic)0.190.210.150.140.110.480.150.14
Earnings Per Share (Diluted)0.190.200.150.140.110.460.150.13
Weighted Average Shares Outstanding (Basic)236,073238,299238,603241,491237,775233,084234,571232,418
Weighted Average Shares Outstanding (Diluted)239,956244,905244,664248,608244,676243,342244,804242,167

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ADMA

ADMA Biologics Inc (NASDAQ: ADMA) is a stock listed on the Nasdaq Stock Market under the ticker symbol ADMA. It last traded at $13.68 (Nov 13, 2026, 4:00 PM ET), up 3.3% on the day. That gives ADMA Biologics a market capitalisation of $2.9B and a price-to-earnings ratio of 17.4.

Over the past 52 weeks ADMA has traded between $7.21 and $20.46.

Revenue for the quarter ended Mar 31, 2026 was $114.5M; net income $45.3M. Revenue was down 0.3% from $114.8M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$114.5M$45.3M39.6%
Dec 31, 2025$139.2M$49.4M35.5%
Sep 30, 2025$134.2M$36.4M27.1%
Jun 30, 2025$122.0M$34.2M28.1%

From ADMA Biologics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…